Medtronic reported FY2025 revenue of $33.54 billion and fiscal Q3 2026 revenue of $9.02 billion, keeping the thesis on whether device innovation can translate into durable margins, cash flow and balance-sheet discipline.
Medtronic: the device giant has scale, but the proof is durable growth after reinvestment
NYSEMDTCoverage BootstrapMedtronic plc
Thesis summary
Medtronic reported FY2025 revenue of $33.54 billion and fiscal Q3 2026 revenue of $9.02 billion, keeping the thesis on whether device innovation can translate into durable margins, cash flow and balance-sheet discipline.
View article
Discuss the thesis
0 commentsCommenting requires active membershipBecome a member
Attack the thesis, not the person.Add evidence when challenging claims.No pump, spam, or low-effort comments.
No comments yet. Start the discussion with evidence, a question, or a bear case.